Low-Dose Enkephalin Blocked Substance P Pain Without Producing Direct Pain Relief
Met-enkephalin at doses too low for pain relief specifically blocked the aversive behavior caused by substance P — showing it can selectively modulate pain signaling.
Quick Facts
What This Study Found
Intrathecal (spinal cord) met-enkephalin at low doses markedly reduced the aversive behavior caused by intrathecal substance P. At these same low doses, met-enkephalin produced no measurable analgesia in the tail-flick pain test.
Met-enkephalin needed much higher doses to produce general analgesia.
Beta-endorphin and dynorphin-(1-17) were different. They blocked substance P-induced behavior and produced general analgesia at roughly the same doses. There was no separation between the two effects.
This suggests met-enkephalin has a specific, preferential interaction with substance P-mediated pain signaling in the spinal cord, separate from its general painkilling effects.
Key Numbers
How They Did This
Mice received intrathecal injections of substance P (to cause aversive behavior) followed by intrathecal met-enkephalin, beta-endorphin, or dynorphin. Aversive behavior was scored. General pain relief was measured by tail-flick test. Multiple doses tested for each peptide.
Why This Research Matters
Substance P is one of the main pain neurotransmitters in the spinal cord. Finding that met-enkephalin specifically counteracts substance P at very low doses suggests a targeted interaction between the enkephalin and substance P systems. This could inform development of spinal pain treatments.
The Bigger Picture
Pain has both sensory and emotional components. This study showed enkephalin can selectively target the emotional/aversive component at low doses, potentially enabling more targeted pain treatment.
What This Study Doesn't Tell Us
Tested in mice, not people. Intrathecal injection is an invasive route not commonly used clinically. Only one aversive behavior model was tested. The mechanism of enkephalin-substance P interaction was not identified.
Questions This Raises
- ?Could low-dose enkephalin treat pain suffering without complete anesthesia?
- ?Does this selectivity translate to clinical pain management?
Trust & Context
- Key Stat:
- Aversion blocked without analgesia At doses too low for direct pain relief
- Evidence Grade:
- Preliminary animal study with elegant dose separation but limited to one behavioral model.
- Study Age:
- Published in 1988 — early evidence for dissociable pain components modulated by opioid peptides.
- Original Title:
- Enkephalins interact with substance P-induced aversive behaviour in mice.
- Published In:
- Brain research, 442(1), 191-4 (1988)
- Authors:
- Sakurada, T(2), Takahashi, K, Sakurada, S(2), Kisara, K, Folkesson, R, Terenius, L
- Database ID:
- RPEP-00090
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is substance P?
A neuropeptide that transmits pain signals and causes inflammation. It is a key player in pain transmission from the spinal cord to the brain.
Why is blocking aversion without analgesia useful?
Pain has two components: the sensation and the suffering. Targeting the suffering component could reduce pain distress while preserving protective pain awareness.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00090APA
Sakurada, T; Takahashi, K; Sakurada, S; Kisara, K; Folkesson, R; Terenius, L. (1988). Enkephalins interact with substance P-induced aversive behaviour in mice.. Brain research, 442(1), 191-4.
MLA
Sakurada, T, et al. "Enkephalins interact with substance P-induced aversive behaviour in mice.." Brain research, 1988.
RethinkPeptides
RethinkPeptides Research Database. "Enkephalins interact with substance P-induced aversive behav..." RPEP-00090. Retrieved from https://rethinkpeptides.com/research/sakurada-1988-enkephalins-interact-with-substance
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.